Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

被引：132

作者：

Klein, Thomas W. ^{[1
]}

Cabral, Guy A. ^{[2
]}

机构：

[1] Univ S Florida, Dept Med Microbiol & Immunol, Coll Med, Tampa, FL 33612 USA

[2] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA

来源：

JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 2006年 / 1卷 / 01期

关键词：

Fatty Acid Amide Hydrolase; Vanilloid Receptor; Palmitoylethanolamide; Ajulemic Acid; Noladin Ether;

D O I：

10.1007/s11481-005-9007-x

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The study of marijuana cannabinoid biology has led to many important discoveries in neuroscience and immunology. These studies have uncovered a new physiological system, the endocannabinoid system, which operates in the regulation of not only brain function but also the regulation of the immune system. Studies examining the effect of cannabinoid-based drugs on immunity have shown that many cellular and cytokine mechanisms are suppressed by these agents leading to the hypothesis that these drugs may be of value in the management of chronic inflammatory diseases. In this report, we review current information on cannabinoid ligand and receptor biology, mechanisms involved in immune suppression by cannabinoids with emphasis on antigen-presenting cells, and preclinical and clinical models analyzing the therapeutic potential of cannabinoid-based drugs.

引用

页码：50 / 64

页数：15

共 133 条

[1]

Arévalo-Martin A, 2003, J NEUROSCI, V23, P2511

[2] Endocannabinoids control spasticity in a multiple sclerosis model [J].

Baker, D ;

Pryce, G ;

Croxford, JL ;

Brown, P ;

Pertwee, RG ;

Makriyannis, A ;

Khanolkar, A ;

Layward, L ;

Fezza, F ;

Bisogno, T ;

Di Marzo, V .

FASEB JOURNAL, 2001, 15 (02) :300-302

[3] Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].

Baker, D ;

Pryce, G ;

Croxford, JL ;

Brown, P ;

Pertwee, RG ;

Huffman, JW ;

Layward, L .

NATURE, 2000, 404 (6773) :84-87

[4] The therapeutic potential of cannabis [J].

Baker, D ;

Pryce, G ;

Giovannoni, G ;

Thompson, AJ .

LANCET NEUROLOGY, 2003, 2 (05) :291-298

[5] Influence of fatty acid ethanolamides and Delta(9)-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells [J].

Berdyshev, EV ;

Boichot, E ;

Germain, N ;

Allain, N ;

Anger, JP ;

Lagente, V .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 330 (2-3) :231-240

[6] Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain [J].

Bisogno, T ;

Howell, F ;

Williams, G ;

Minassi, A ;

Cascio, MG ;

Ligresti, A ;

Matias, I ;

Schiano-Moriello, A ;

Paul, P ;

Williams, EJ ;

Gangadharan, U ;

Hobbs, C ;

Di Marzo, V ;

Doherty, P .

JOURNAL OF CELL BIOLOGY, 2003, 163 (03) :463-468

[7] Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide [J].

Bisogno, T ;

Hanus, L ;

De Petrocellis, L ;

Tchilibon, S ;

Ponde, DE ;

Brandi, I ;

Moriello, AS ;

Davis, JB ;

Mechoulam, R ;

Di Marzo, V .

BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :845-852

[8] INVITRO AND INVIVO SUPPRESSIVE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL ON INTERFERON-PRODUCTION BY MURINE SPLEEN-CELLS [J].

BLANCHARD, DK ;

NEWTON, C ;

KLEIN, TW ;

STEWART, WE ;

FRIEDMAN, H .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1986, 8 (07) :819-824

[9] CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].

BOUABOULA, M ;

RINALDI, M ;

CARAYON, P ;

CARILLON, C ;

DELPECH, B ;

SHIRE, D ;

LEFUR, G ;

CASELLAS, P .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180

[10] An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis [J].

Brady, CM ;

DasGupta, R ;

Dalton, C ;

Wiseman, OJ ;

Berkley, KJ ;

Fowler, CJ .

MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (04) :425-433

← 1 2 3 4 5 6 7 8 9 10 →